Synergistic topical application of salt-processed Phellodendron amurense and Sanguisorba officinalis Linne alleviates atopic dermatitis symptoms by reducing levels of immunoglobulin E and pro-inflammatory cytokines in NC/Nga mice

Park,Sunmin; Kim,Da  Sol; Kang,Suna; Shin,Bae  Keun

doi:10.3892/mmr.2015.4348

Synergistic topical application of salt-processed Phellodendron amurense and Sanguisorba officinalis Linne alleviates atopic dermatitis symptoms by reducing levels of immunoglobulin E and pro-inflammatory cytokines in NC/Nga mice

Authors:
- Sunmin Park
- Da Sol Kim
- Suna Kang
- Bae Keun Shin
View Affiliations

Affiliations: Department of Food and Nutrition, Obesity/Diabetes Research Center, Hoseo University, Asan, Chungnam 336‑795, Republic of Korea
Published online on: September 22, 2015 https://doi.org/10.3892/mmr.2015.4348
Pages: 7657-7664

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atopic dermatitis is a chronic inflammatory skin disease, and salt-processed Phellodendron amurense (CPE) and Sanguisorba officinalis Linne (SOE) are widely used as anti-inflammatory agents in Asia. Therefore, the present study investigated the efficacy of CPE, SOE, and CPE+SOE in the treatment of atopic dermatitis-like symptoms in mice. Following topical application of 1,3‑butylen glycol (control), 30% CPE, 30% SOE, 15% CPE+15% SOE or 0.1% hydrocortisone (HC) on the atopic dermatitis‑like skin lesions of 2,4-dinitrochlorobenzene‑treated NC/Nga mice for 5 weeks, the severity of clinical atopic dermatitis, mast cell infiltration, serum expression levels of immunoglobulin (Ig)E, IgG1, interleukin (IL)-4 and interferon (IFN)-γ, and cytokine expression in the dorsal skin were measured. Compared with the control group, treatment with CPE alleviated the clinical severity of the AD symptoms, with decreased numbers of mast cells, decreased expression levels of serum tumor necrosis factor (TNF)‑α, IL‑4 and IFN‑γ, and decreased expression levels of inflammatory cytokines in the dorsal lesions. Treatment with SOE did not reduce these expression levels, however, the serum expression levels of IgE and IgG1 were suppressed to similar levels as those in the CPE group. Furthermore, synergistic treatment with CPE and SOE relieved the clinical severity of atopic dermatitis, reduced the serum expression levels of IgE, IgG1, TNF‑α, IL‑4 and IFN‑γ, and suppressed the mRNA expression levels of TNF‑α, IL‑4, IL‑13, and IFN‑γ in the dorsal skin lesions. Treatment with CPE+SOE was superior to treatment with HC alone for reducing dermal thickness and suppressing the production of several cytokines. Therefore, combined treatment with CPE and SOE may be an effective alternative intervention for the management of atopic dermatitis.

View Figures

View References

1	Williams HC: Clinical practice. Atopic dermatitis. N Engl J Med. 352:2314–2324. 2005. View Article : Google Scholar : PubMed/NCBI
2	Leung DYM: New insights into the complex gene-environment interactions evolving into atopic dermatitis. J Allergy Clin Immunol. 118:37–39. 2006. View Article : Google Scholar
3	Esparza-Gordillo J, Weidinger S, Fölster-Holst R, Bauerfeind A, Ruschendorf F, Patone G, Rohde K, Marenholz I, Schulz F, Kerscher T, et al: A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet. 41:596–601. 2009. View Article : Google Scholar : PubMed/NCBI
4	Bieber T: Atopic dermatitis. N Engl J Med. 358:1483–1494. 2008. View Article : Google Scholar : PubMed/NCBI
5	Leung AK and Barber KA: Managing childhood atopic dermatitis. Adv Ther. 20:129–137. 2003. View Article : Google Scholar : PubMed/NCBI
6	Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ and Tazi-Ahnini R: New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol. 118:3–21. 2006. View Article : Google Scholar : PubMed/NCBI
7	Danby SG and Cork MJ: The effects of pimecrolimus on the innate immune response in atopic dermatitis. Br J Dermatol. 168:235–236. 2013. View Article : Google Scholar : PubMed/NCBI
8	Kim EC, Lee HS, Kim SK, Choi MS, Lee S, Han JB, An HJ, Um JY, Kim HM, Lee NY, et al: The bark of Betula platyphylla var.japonica inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol. 116:270–278. 2008. View Article : Google Scholar : PubMed/NCBI
9	Choi YY, Kim MH, Han JM, Hong J, Lee TH, Kim SH and Yang WM: The anti-inflammatory potential of Cortex Phellodendron in vivo and in vitro: Down-regulation of No and iNOS through suppression of NF-κB and MAPK activation. Int Immunopharmacol. 19:214–220. 2014. View Article : Google Scholar : PubMed/NCBI
10	Park S, Lee JB and Kang S: Topical application of Chrysanthemum indicum L. Attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-γ and IL-4 in Nc/Nga mice. Evid Based Complement Alternat Med. 2012:8219672012. View Article : Google Scholar
11	Xian YF, Mao QQ, Ip SP, Lin ZX and Che CT: Comparison on the anti-inflammatory effect of cortex Phellodendri chinensis and cortex Phellodendri amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharmacol. 137:1425–1430. 2011. View Article : Google Scholar : PubMed/NCBI
12	Gong F, Shen Y, Zhang Q, Sun Y, Tang J, Tao F and Xu Q: Obaculactone suppresses Th1 effector cell function through down-regulation of T-bet and prolongs skin graft survival in mice. Biochem Pharmacol. 80:218–225. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zhang C: Determination of obacunone and obaculactone in different processing products of Phellodendria murensis cortex. Zhong Yao Cai. 36:205–208. 2013.In Chinese. PubMed/NCBI
14	Cai Z, Li W, Wang H, Yan W, Zhou Y, Wang G, Cui J and Wang F: Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L. Int J Biol Macromol. 51:484–488. 2012. View Article : Google Scholar : PubMed/NCBI
15	Yu T, Lee YJ, Yang HM, Han S, Kim JH, Lee Y, Kim C, Han MH, Kim MY, Lee J and Cho JY: Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE₂ production is mediated by suppression of NF-κB and AP-1 activation signaling cascade. J Ethnopharmacol. 134:11–17. 2011. View Article : Google Scholar
16	Hayakawa R: Human closed patch test. Skin Res. 26:1119–1127. 1984.In Japanese.
17	Zhishen J, Mengcheng T and Jianming W: The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 64:555–559. 1999. View Article : Google Scholar
18	Rao TM, Rao BG and Rao YV: Antioxidant activity of Spilanthes acmella extracts. Int J Phytopharmacol. 3:216–220. 2012.
19	Mills LB, Mordan LJ, Roth HL, Winger EE and Epstein WL: Treatment of severe atopic dermatitis by topical immune modulation using dinitrochlorobenzene. J Am Acad Dermatol. 42:687–689. 2000. View Article : Google Scholar : PubMed/NCBI
20	Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J and Taïeb A: Clinical validation and guidelines for the SCORAD index: Consensus report of the european task force on atopic dermatitis. Dermatology. 195:10–19. 1997. View Article : Google Scholar : PubMed/NCBI
21	Ong PY and Leung DY: Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 6:384–389. 2006. View Article : Google Scholar : PubMed/NCBI
22	Abramovits W: A clinician's paradigm in the treatment of atopic dermatitis. J Am Acad Dermatol. 53(1 Suppl 1): S70–S77. 2005. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW and Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 9:461–466. 1997. View Article : Google Scholar : PubMed/NCBI
25	Takahashi N, Arai I, Honma Y, Hashimoto Y, Harada M, Futaki N, Sugimoto M and Nakaike S: Scratching behavior in spontaneous- or allergic contact-induced dermatitis in NC/Nga mice. Exp Dermatol. 14:830–837. 2005. View Article : Google Scholar : PubMed/NCBI
26	Hashimoto Y, Takaoka A, Sugimoto M, Honma Y, Sakurai T, Futaki N and Arai I: Itch-associated scratching contributes to the development of dermatitis and hyperimmunoglobulinaemia E in NC/Nga mice. Exp Dermatol. 20:820–825. 2011. View Article : Google Scholar : PubMed/NCBI
27	Vailes LD, Perzanowski MS, Wheatley LM, Platts-Mills TA and Chapman MD: IgE and IgG antibody responses to recombinant Alt a 1 as a marker of sensitization to alternaria in asthma and atopic dermatitis. Clin Exp Allergy. 31:1891–1895. 2001. View Article : Google Scholar : PubMed/NCBI
28	Galli SJ and Tsai M: IgE and mast cells in allergic disease. Nat Med. 18:693–704. 2012. View Article : Google Scholar : PubMed/NCBI
29	Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T and Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 19:359–361. 1998. View Article : Google Scholar : PubMed/NCBI
30	Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS and Chan LS: Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol. 138:375–387. 2004. View Article : Google Scholar : PubMed/NCBI
31	Yamanaka K and Mizutani H: The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol. 41:80–92. 2011. View Article : Google Scholar : PubMed/NCBI